Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 14.30
-0.20 (-1.38%)
Mar 4, 2026, 3:45 PM CET
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 100.95 million as of March 4, 2026. Its market cap has decreased by -47.39% in one year.
Market Cap
100.95M
Enterprise Value
73.55M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.30
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 100.95M, an increase of 101.04%. That is a compound annual growth rate of 8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 100.95M | -27.78% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 150.38M |
| Active Biotech AB | 137.34M |
| IRLAB Therapeutics AB | 131.82M |
| Simris Group AB (PUBL) | 128.23M |
| Xbrane Biopharma AB | 127.86M |
| Biovica International AB | 105.09M |
| Alligator Bioscience AB | 102.73M |
| Biosergen AB | 90.17M |